Quantum Units Education: New CEU Courses

Opioid Use Disorder: Partnering Clients, Health Care, and Addiction Professionals

Opioid misuse has caused a growing nationwide epidemic of OUD and unintentional overdose deaths.  This CEU course provides information for professionals working with individual who take a Food and Drug Administration-approved medication for opioid use disorder.

Chronic Pain and Opioid Misuse

The crisis of prescription opioid related harms has focused attention toward identifying and treating high-risk populations.  This CE course reviews the epidemiology and clinical management of comorbid chronic pain and prescription opioid or other substance misuse.

For more on these new courses and many more, visit our course page

 

Quantum Units Education: New CEU Courses

Opioid Use Disorder: Medications, Screening, and Assessment

The number of patients presenting with opioid use disorder (OUD) in medical clinics, community health centers, and private practices is increasing.  This CEU course offers a general introduction to providing medications to address OUD and addresses most personal healthcare needs, development of sustained partnerships with patients, and practicing in the context of family and community.

Opioid Use Disorder: Medications, Screening, and Assessment – For Social Workers

The number of patients presenting with opioid use disorder (OUD) in medical clinics, community health centers, and private practices is increasing.  This CEU course offers social workers a general introduction to OUD medications and addresses most personal healthcare needs, development of sustained partnerships with patients, and practicing in the context of family and community.

Responding to Girls in Gangs

This CEU course identifies girls’ reasons for joining gangs, their experiences and activities related to gang involvement, and their motivations and strategies for transitioning away from gangs.  Also provided are recommendations for those who are interested in improving outcomes for gang-involved girls.

For more on these new courses and many more, visit Quantum Units Education

Quantum Units Education: New CEU Courses

Treating Pregnant and Parenting Women with Opioid Use Disorder

The nation’s opioid epidemic continues to compromise the health and well-being of individuals, families, and communities.  This CE course provides comprehensive, national guidance for the optimal management of pregnant and parenting women with an opioid use disorder (OUD) and their infants.

PTSD and Accelerated Aging

Investigators have suggested that aspects of the intra-individual environment, such as psychiatric symptoms, may impact physiology directly and be as important as the external environment, if not more so, in predicting subsequent health outcomes.  This CE course explores the growing empirical literature concerning PTSD-related accelerated aging and the methodologies used to study it.

For more on these new courses and many more, visit Quantum Units Education

Why are doctors underusing a drug to treat opioid addiction?

A drug approved for private physicians to treat opioid addiction is being underprescribed, and a survey of addiction specialists suggests that many of them are not willing to increase their use of it, despite an expanding opioid addiction epidemic in the United States, according to research presented at the 125th Annual Convention of the American Psychological Association.

Two opioid replacement medications are currently approved for opioid use disorder: methadone, which under federal law must be dispensed from authorized clinics, and buprenorphine, which can be used to treat opioid addiction in the privacy of a physician’s office, so long as the physician has the proper waivers.

Full story at Science Daily

‘Alarmingly high’ risk of death for people with opioid use disorder in general medical care

Almost one-fifth of patients with opioid use disorder (OUD) in a large healthcare system died during a four-year follow-up period, reports a study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM). The journal is published by Wolters Kluwer.

The results suggest very high rates of serious illness and death among patients with OUD in general medical care settings — much higher than for those in addiction specialty clinics, according to by Yih-Ing Hser, PhD, of University of California, Los Angeles, and colleagues. They write, “The alarmingly high morbidity and mortality among OUD patients revealed in the present study challenge healthcare systems to find new and innovative ways to expand evidence-based strategies for OUD in a variety of settings.”

Full story of death risk for opioid users in general medical care at Science Daily